Exact Sciences Corporation (EXAS) CEO Kevin Conroy on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 10/30/20
Exact Sciences Commends Task Force for Draft Updated Guidelines that include Colorectal Cancer Screening Beginning at Age 45PRNewsWire • 10/27/20
Exact Sciences soars 33% after agreeing to acquire early cancer detection firm for $2.15 billion (EXAS)Business Insider • 10/27/20
Exact Sciences to acquire Thrive Earlier Detection Corp. in cash and stock deal worth up to $2.15 billionMarket Watch • 10/27/20
Exact Sciences Announces Entry into Agreements to Sell $869 Million of Common Stock in Registered Direct OfferingPRNewsWire • 10/27/20
Was The Smart Money Right About Crowding Into EXACT Sciences Corporation (EXAS)?Insider Monkey • 10/27/20
Analysts Estimate Exact Sciences (EXAS) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 10/22/20
Exact Sciences Introduces the Oncotype MAP™ Pan-Cancer Tissue Test to Help Guide Treatment for Patients with Advanced CancerPRNewsWire • 10/12/20
Coronavirus Drives Testing Stocks: Is There Room for More Upside?Zacks Investment Research • 10/06/20
Why Is Exact Sciences (EXAS) Down 25.3% Since Last Earnings Report?Zacks Investment Research • 08/29/20